Related Experiment Videos
Remodeling the cardiac sarcomere using transgenesis
1Department of Pediatrics, Children's Hospital Research Foundation, Cincinnati, Ohio 45229-3039, USA. jeff.robbins@chmcc.org
Insights
Establishing causative links between specific cardiac proteins and heart conditions requires targeted genetic modification. Transgenesis allows researchers to precisely alter heart protein profiles, enabling studies on the molecular and physiological consequences of these changes.
Area of Science:
- Cardiovascular Physiology
- Molecular Cardiology
- Genetics
Background:
- Cell and organ function are underpinned by specific protein complements.
- Contractile protein alterations in the heart correlate with functional changes during development and disease.
- Establishing causative proof for these protein-function relationships has been a challenge.
Purpose of the Study:
- To establish causative proof for the role of specific cardiac proteins in heart function and pathology.
- To investigate the consequences of altering cardiac protein profiles using genetic manipulation.
- To understand the molecular, biochemical, cytological, and physiological effects of defined genetic changes in the heart.
Main Methods:
- Utilizing transgenesis to stably modify the mammalian genome.
- Directing the expression of engineered proteins specifically to the heart.
- Remodeling cardiac contractile protein profiles through genetic engineering.
Main Results:
- The study proposes a method to directly link protein changes to functional outcomes.
- Transgenic models allow for the study of single genetic manipulations in the heart.
- This approach enables the determination of protein function and isoform effects.
Conclusions:
- Transgenesis offers a powerful tool to establish causative relationships between cardiac proteins and heart conditions.
- Precisely altering cardiac protein complements in vivo facilitates detailed investigation of protein function.
- This methodology is crucial for understanding the pathophysiology of various heart diseases.
Abstract:
An underpinning of basic physiology and clinical medicine is that specific protein complements underlie cell and organ function. In the heart, contractile protein changes correlating with functional alterations occur during both normal development and the development of numerous pathologies. What has been lacking for the majority of these observations is an extension of correlation to causative proof. More specifically, different congenital heart diseases are characterized by shifts in the motor proteins, and the genetic etiologies of a number of different dilated and hypertrophic cardiomyopathies have been established as residing at loci encoding the contractile proteins. To establish cause, or to understand development of the pathophysiology over an animal's life span, it is necessary to direct the heart to synthesize, in the absence of other pleiotropic changes, the candidate protein. Subsequently one can determine whether or how the protein's presence causes the effects either directly or indirectly. By affecting the heart's protein complement in a defined manner, the potential to establish the function of different proteins and protein isoforms exists. Transgenesis provides a means of stably modifying the mammalian genome. By directing expression of engineered proteins to the heart, cardiac contractile protein profiles can be effectively remodeled and the resultant animal used to study the consequences of a single, genetic manipulation at the molecular, biochemical, cytological, and physiological levels.